Neurana appears to be having success in the development of a non-opioid pain reliever using Tolperisone for acute muscle spasms. They are now in phase 3 trials. Neurana is a privately held company. Does anyone know who their industry partner might be? Any ideas on how to invest in their future upside before they get […]
Microblogs
January 4, 2021
Dylan Jovine’s Melanoma Teaser
Just read about a phase 3 Melanoma treatment study today, a “Takeover Target”. I’m not a subscriber to Takeover Targets. He says this company is likely a takeover target by Astra Zeneca, and they are already partnered with Astra Zeneca. It’s a therapy which makes a treatment out of your own tumor. I have a […]
Recent Author Comments
Posted on January 4, 2021
Posted on January 4, 2021
Also I forgot to mention that Neurana is partnered with Sanochemia Pharmazeutika (Austria) using their drug, Tolperisone. Sanochemia is not public either, I believe. From Sanochemia's website:NeurologyTolperisone is a muscle relaxant developed for the tr[...]
Posted on December 16, 2020
I watched that video. I researched as well and was pretty convinced the company he was referencing was Editas. I took a chance and bought a sizeable chunk of the stock, and am glad I did. However, the news that the stock surged on had to do with sickle ce[...]
Posted on December 11, 2020
My educated guess is Editas. I'm all but certain. Look at my postings on Redditt.[...]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info Please note that this is your publicly visible biography - we recommend not including any personal information (phone, email, address, etc.) and ONLY linking to any other pages or profiles you're comfortable sharing with everyone.
Have been researching Dylan Jovine's Takeover Target and it looks like Iovance Biotherapeutics. (IOVA). Would love to hear some thoughts on it....[...]